Bariatric surgery for weight loss has become a common practice in the United States with about 179,000 operations being performed in 2013. The second most common bariatric procedure done today is the Roux-en-Y gastric bypass (RYGB). To be a practicing health profession in the modern era, one must understand the more common chronic complications that may result from altering the gastrointestinal (GI) tract and how to manage these complications.
To understand the sequela of the operation, one must have a basic understanding of the anatomy of the GI tract and the resulting physiologic effects of altering that anatomy. Roux-en-Y gastric bypass involves creating a small gastric pouch (restricting food intake) connected to a roux limb (typically between 75 to 150 cm) which bypasses a large portion of the small intestine (preventing absorption of nutrients.) This results in the food bolus bypassing the majority of the stomach (bypasses the part of the stomach containing most of the parietal cells and stomach acid), the duodenum, and the first 40 to 50 cm of jejunum. Nutrients will only be absorbed distal to these bypassed segments, and the majority will be absorbed in the "common channel" which is distal to the where the biliopancreatic and the roux limb connect.
The common chronic complications following an RYGB are briefly described with respect to epidemiology, presentation, diagnosis, and treatment.
The most common place for a stricture is at the gastrojejunal anastomosis; this occurs between 3% to 7% following laparoscopic RYGB procedures (LRYGB). The pathophysiologies responsible for the formation of this stricture are ischemia, scarring, and inadequate technique (creating a small anastomosis). Patients will typically present weeks to months postoperatively with progressive dysphagia of solids to liquids and subsequent daily vomiting. Diagnosis is made with endoscopic evaluation. Treatment is primarily with endoscopic balloon dilation and in the setting of failure or multiple recurrences may need surgical revision.,
Marginal ulceration is described as an appearance of a peptic ulcer on the jejunal mucosa at the gastrojejunal anastomosis. It is diagnosed in 1% to 16% of patients who undergo LRYGB. The pathology is a result of acid insult to the relatively unprotected jejunal mucosa. Several mechanisms have been implicated in a marginal ulcers development:
About one-third of patients will present within the first 3 months after surgery and about one-half will present after 1 year. The most common presenting sign will be epigastric pain and patients may less commonly present with nausea, vomiting, dysphagia, bleeding, or chronic anemia. Diagnosis is with upper endoscopy and treatment is typically accomplished with proton pump inhibitors and repeat endoscopy to ensure healing. Medical treatment is successful in 85% to 95% of cases. Complications of marginal ulceration include perforation, stricture, and bleeding. Perforated ulcers typically require emergent surgery with a graham patch closure and distal feeding tube placement. Strictures and bleeding unresponsive to medical and endoscopic measures may need a surgical revision of the gastrojejunostomy.
Gastro-Gastric Fistula (GGF)
GGF is an abnormal connection between the surgically created pouch and excluded remnant stomach. It occurs in approximately 1% to 2% of patients undergoing RYGB with a divided stomach (historically the stomach was stapled and left undivided leading to an unacceptable rate of GGF). Etiologies of a GGF include an incomplete transection of the stomach, anastomotic leak, marginal ulcer perforation and foreign body erosion. Patients will typically present with weight gain as the classic sign however intractable marginal ulceration may also GGF formation. Diagnosis is usually confirmed with a CT scan or UGI study. Treatment of GGF will include a PPI for all patients. Endoscopic treatments of small fistulae with clips may be successful however surgical treatment is usually necessary. Surgical options include remnant gastrectomy, transection of the fistulous transect, and revision of the gastrojejunal anastomosis.
Historically, the incidence of new gallstone formation following gastric bypass surgery ranges from 32% to 42% and about one-third to one-half of those patients became symptomatic. Increased gallstone formation in RYGB patients is caused by supersaturation of bile with cholesterol secondary to a reduction in bile acid secretion because of the caloric restriction. Another reason is limited gallbladder contractility and emptying secondary to a reduction in secretion of cholecystokinin (CCK) due to the bypassed duodenum. Most gallstones are formed within the first 6 months postoperatively.
Management of gallstones with RYGB is a controversial subject with many options. First, we must understand that the addition of a cholecystectomy to a laparoscopic RYGB adds about 18 minutes and has added complications associated with it. All patients should be evaluated for gallstones either by preoperative ultrasound or intraoperative ultrasound. This will create 2 categories of patients based on the presence or absence of gallstones.
Presence of Gallstones
Absence of Gallstones
Patients should receive ursodeoxycholic acid (UDCA) 600 mg per day for 6 months postoperatively, which effectively reduces gallstone formation to 2% within that timeframe. 
Patients may present with stones in the common bile duct and resultant cholangitis or pancreatitis. A useful diagnostic tool would be MRCP in this setting. The usual treatment being conventional ERCP is not feasible since the duodenum is excluded and connected to the remnant stomach. Options in this situation are double balloon enteroscopy, laparoscopic-assisted ERCP with a remnant stomach gastrostomy, percutaneous transhepatic cholangiography, and open common bile duct exploration. 
Small Bowel Obstruction (SBO)
In the setting of LRYGB, the incidence of SBO is between 1.5% to 5%. The etiology of SBO in an RYGB patient can generally be attributed to internal hernias, adhesions or strictures. There are 3 potential sites for internal hernia formation in an RYGB patient depending on the technique used. If a retrocolic roux limb technique is used this creates a defect in the mesocolon, a defect in mesentery at jejunojejunostomy, and the Petersen’s defect (bordered by the roux limb mesentery, transverse mesocolon, and the retroperitoneum). The number one cause of SBO in postoperative LRYGB has historically been an internal hernia, however, in patients who have undergone an antecolic reconstruction, the most common cause may be a stricture or adhesions. Historically when a patient had an open RYGB there was a decrease in the formation of an internal hernia due to intraabdominal adhesions which, in theory, does not allow the loops of bowel to slip into the mesenteric defects.
Patients may present with vague, crampy abdominal pain with or without vomiting. This can be an acute or subacute presentation and may be intermittent. In a gastric bypass patient, these symptoms must be worked up promptly with a CT scan to look for an internal hernia. A CT scan has a lower sensitivity for diagnosing SBO in LRYGB when compared to the general public. Treatment is exploration, either laparoscopically or open, and specifics of the operation are related to the etiology of obstruction. In a patient who has a negative CT scan but has continued obstructive symptoms, diagnostic laparoscopy must be considered.
Dumping syndrome can be classified as either early or late and encompass different clinical presentations. The prevalence of dumping syndrome post RYGB with a median follow up of 4.5 years is about 13% and is more commonly found in young females. 
Early Dumping Syndrome
Occurs within the first hour after ingesting a meal (usually within 10 to 30 minutes) and is attributed to the rapid introduction of nutrients into the small bowel causing an osmotically driven movement of fluid into the small bowel lumen. This will typically present with diarrhea, dizziness, flushing, and possibly hypotension. First line treatment is with a low carbohydrate, high protein/fiber diet taken in small/frequent meals. If one has persistent symptoms, then octreotide can be used. This is typically a self-limiting decease and subsides in 12 to 18 months following surgery.
Late Dumping Syndrome
Occurs between 1 to 3 hours after a meal and is a hypoglycemic response to hyperinsulinemia. This will present as tremors, diaphoresis, palpitations, and altered mental status. The first step in treatment is as above with diet modification and octreotide. If the effects of hypoglycemia are debilitating, then surgical intervention may be required. Accepted methods include reversal of bypass to normal anatomy, surgeries to increase gastric reservoir, and conversion to sleeve gastrectomy. 
The incidence of low B12 one year postoperatively from an RYGB surgery is estimated to be around 30% to 35% but may be higher. Vitamin B12 is released from food by the action of stomach acid. An R binder protein then binds it. This bond is cleaved by pancreatic enzymes allowing B12 to complex with intrinsic factor(IF), a protein synthesized by parietal cells in the stomach. This complex is then absorbed in the terminal ileum. RYGB will alter all of the above processes leading to a vitamin B12 deficiency in the absence of supplementation. The liver can store a large amount of B12 which may defer the development of B12 deficiency syndrome for years. Patients are often asymptomatic but may present with megaloblastic anemia and neurological symptoms (paresthesias, unsteady gait, poor memory, agitation, confusion, depression.) Diagnosis is based on low serum vitamin B12 levels; if this is equivocal, it may be confirmed with a methylmalonic acid and homocysteine levels. Treatment is primarily preventative as some of the sequelae are irreversible. Supplementation after surgery may be with daily orals or monthly injections.,,
The incidence of low serum folate after RYGB is between 6% to 35%. Folic acid is absorbed through the majority of the jejunum and deficiency usually results from an insufficient intake. Deficiency can result in megaloblastic anemia and sometimes with irritability, forgetfulness or paranoid behavior. Treatment of deficiency is accomplished with a supplement of 1 mg per day, and symptoms will quickly resolve in 24 hours usually. Prevention is with 400 micrograms daily with a multivitamin.,
Thiamine deficiency is one of the most serious vitamin deficiencies after an RYGB. It is a water-soluble vitamin that is primarily absorbed in the jejunum. Only small amounts of thiamine are stored in the body, and a continuous exogenous supply is needed to maintain adequate levels. Deficiency may develop in the setting of decreased intake in an RYGB patient. A patient may present with a wide array of clinic syndromes which are well known as dry beriberi (neuropathic symptoms), wet beriberi (heart failure symptoms), or Wernicke’s encephalopathy (triad of ophthalmoplegia, ataxia, nystagmus). Patients with subclinical deficiency may present with irritability, headaches, and fatigue. If symptomatic the patient will need IV repletion and supplementation until all symptoms resolve. Prevention is with a daily multivitamin that contains 200% of the daily requirements.
Iron deficiency is the most common nutritional deficiency in an RYGB patient with a prevalence of 30% to 50%. Iron absorption is promoted when exposed to gastric acid and duodenal proteolytic enzymes resulting in molecular transformations. It can be absorbed at any level in the intestinal tract but is the most efficient in the duodenum. Deficiency in RYGB patients is due to the bypass of the mechanism mentioned above of absorption or due to slow chronic bleeding from marginal ulceration. Patients may present with fatigue and generalized weakness. Diagnosis is confirmed with laboratory tests showing microcytic anemia, elevated total iron binding capacity, low ferritin and low serum iron levels. Treatment is with oral supplementation, and if unsuccessful at correction or the patient is unable to tolerate the oral form, IV supplementation can be offered. Prevention is with daily oral supplementation, which may be included in a multivitamin. Menstruating women require higher doses than women who are not menstruating.
Calcium and Vitamin D
There is a high prevalence of vitamin-D deficiency and resulting secondary hyperparathyroidism in obese patients preoperatively. The obesity, however, results in a higher preoperative bone mineral mass. Calcium is preferentially absorbed in the duodenum and proximal jejunum while vitamin D is primarily absorbed in the distal small bowel. After bypassing these segments, there is malabsorption of calcium with a resulting deficiency leading to a further increase in PTH. The long-term actions of PTH will release calcium from bone causing osteopenia and eventually osteoporosis. Treatment and prevention are with oral supplementation.
Zinc, Copper, Selenium, Vitamin C
These can be deficient in RYGB patient and can rarely be of clinical significance. These are typically supplemented with a daily multivitamin.
Roux-en-Y Gastric Bypass is a commonly performed operation today in the United States. It has many advantages over other weight loss surgeries but can present with early and late complications. Chronic complications include but are not limited to strictures, internal hernias, gastro-gastric fistulae, gallstones, marginal ulcers, dumping syndrome, and the nutritional deficiencies that accompany altering the GI tract. As increasingly more patients will have had this surgery, a healthcare practitioner must be aware of these sequelae and their management.
Indications for surgery
The management of obesity is with a team of an interprofessional professionals that includes an internist, primary care provider, nurse practitioner, dietitian, bariatric surgeon, sociologist, physical therapist, and an endocrinologist. The key to prevention of obesity is patient education about changes in lifestyle and diet. Surgery is usually the last alternative and while it does work, it is also expensive and associated with serious complications.
Roux-en-Y Gastric Bypass is a commonly performed operation today in the United States. It has many advantages over other weight loss surgeries but can present with early and late complications. Chronic complications include but are not limited to strictures, internal hernias, gastro-gastric fistulae, gallstones, marginal ulcers, dumping syndrome, and the nutritional deficiencies that accompany altering the GI tract. As increasingly more patients will have had this surgery, a healthcare practitioner must be aware of these sequelae and their management. Patients need to be made aware that surgery does not cure obesity- it is just a temporary method of inducing weight loss and if the patient does not partake exercise or a change in diet, the weight will soon be regained.
|||Palermo M,Acquafresca PA,Rogula T,Duza GE,Serra E, Late surgical complications after gastric by-pass: a literature review. Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery. 2015 Apr-Jun [PubMed PMID: 26176254]|
|||Goitein D,Papasavas PK,Gagné D,Ahmad S,Caushaj PF, Gastrojejunal strictures following laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surgical endoscopy. 2005 May [PubMed PMID: 15759176]|
|||Rasmussen JJ,Fuller W,Ali MR, Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surgical endoscopy. 2007 Jul [PubMed PMID: 17514403]|
|||Carrodeguas L,Szomstein S,Soto F,Whipple O,Simpfendorfer C,Gonzalvo JP,Villares A,Zundel N,Rosenthal R, Management of gastrogastric fistulas after divided Roux-en-Y gastric bypass surgery for morbid obesity: analysis of 1,292 consecutive patients and review of literature. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2005 Sep-Oct [PubMed PMID: 16925272]|
|||Gumbs AA,Duffy AJ,Bell RL, Management of gastrogastric fistula after laparoscopic Roux-en-Y gastric bypass. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2006 Mar-Apr [PubMed PMID: 16925334]|
|||Villegas L,Schneider B,Provost D,Chang C,Scott D,Sims T,Hill L,Hynan L,Jones D, Is routine cholecystectomy required during laparoscopic gastric bypass? Obesity surgery. 2004 Feb [PubMed PMID: 15018749]|
|||Nagem RG,Lázaro-da-Silva A,de Oliveira RM,Morato VG, Gallstone-related complications after Roux-en-Y gastric bypass: a prospective study. Hepatobiliary [PubMed PMID: 23232635]|
|||Gutierrez JM,Lederer H,Krook JC,Kinney TP,Freeman ML,Jensen EH, Surgical gastrostomy for pancreatobiliary and duodenal access following Roux en Y gastric bypass. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2009 Dec [PubMed PMID: 19777312]|
|||Husain S,Ahmed AR,Johnson J,Boss T,O'Malley W, Small-bowel obstruction after laparoscopic Roux-en-Y gastric bypass: etiology, diagnosis, and management. Archives of surgery (Chicago, Ill. : 1960). 2007 Oct [PubMed PMID: 17938313]|
|||Hwang RF,Swartz DE,Felix EL, Causes of small bowel obstruction after laparoscopic gastric bypass. Surgical endoscopy. 2004 Nov [PubMed PMID: 15931476]|
|||Champion JK,Williams M, Small bowel obstruction and internal hernias after laparoscopic Roux-en-Y gastric bypass. Obesity surgery. 2003 Aug [PubMed PMID: 12935361]|
|||Nielsen JB,Pedersen AM,Gribsholt SB,Svensson E,Richelsen B, Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2016 Sep - Oct [PubMed PMID: 27425831]|
|||Zurita Mv LC,Tabari M,Hong D, Laparoscopic conversion of laparoscopic Roux-en-Y gastric bypass to laparoscopic sleeve gastrectomy for intractable dumping syndrome and excessive weight loss. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2013 Mar-Apr [PubMed PMID: 23369599]|
|||Shuster MH,Vázquez JA, Nutritional concerns related to Roux-en-Y gastric bypass: what every clinician needs to know. Critical care nursing quarterly. 2005 Jul-Sep [PubMed PMID: 16041224]|
|||Alvarez-Leite JI, Nutrient deficiencies secondary to bariatric surgery. Current opinion in clinical nutrition and metabolic care. 2004 Sep [PubMed PMID: 15295278]|
|||Dogan K,Aarts EO,Koehestanie P,Betzel B,Ploeger N,de Boer H,Aufenacker TJ,van Laarhoven KJ,Janssen IM,Berends FJ, Optimization of vitamin suppletion after Roux-en-Y gastric bypass surgery can lower postoperative deficiencies: a randomized controlled trial. Medicine. 2014 Nov [PubMed PMID: 25437032]|
|||Gasteyger C,Suter M,Gaillard RC,Giusti V, Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. The American journal of clinical nutrition. 2008 May [PubMed PMID: 18469230]|